Double Medical Technology Inc. (002901.SZ)
CNY 35.38
(-0.06%)
CNY 35.38
(-0.06%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 58.97 Million CNY | -36.28% |
| 2022 | 92.55 Million CNY | -86.25% |
| 2021 | 673.3 Million CNY | 11.17% |
| 2020 | 605.68 Million CNY | 30.12% |
| 2019 | 465.49 Million CNY | 25.32% |
| 2018 | 371.45 Million CNY | 25.68% |
| 2017 | 295.55 Million CNY | 34.76% |
| 2016 | 219.32 Million CNY | 16.35% |
| 2015 | 188.5 Million CNY | 35.33% |
| 2014 | 139.28 Million CNY | 43.88% |
| 2013 | 96.81 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 61.72 Million CNY | 259.33% |
| 2024 Q2 | 76.51 Million CNY | 23.95% |
| 2024 Q3 | 101.63 Million CNY | 32.83% |
| 2023 Q3 | 4.18 Million CNY | -88.17% |
| 2023 Q4 | -38.74 Million CNY | -1026.75% |
| 2023 Q1 | 58.2 Million CNY | 150.1% |
| 2023 FY | 58.97 Million CNY | -36.28% |
| 2023 Q2 | 35.32 Million CNY | -39.31% |
| 2022 Q4 | -116.17 Million CNY | -457.65% |
| 2022 Q3 | 32.48 Million CNY | -52.49% |
| 2022 Q2 | 68.36 Million CNY | -38.7% |
| 2022 Q1 | 111.52 Million CNY | -49.27% |
| 2022 FY | 92.55 Million CNY | -86.25% |
| 2021 Q4 | 219.82 Million CNY | 61.26% |
| 2021 Q3 | 136.31 Million CNY | -26.94% |
| 2021 FY | 673.3 Million CNY | 11.17% |
| 2021 Q1 | 130.56 Million CNY | -26.68% |
| 2021 Q2 | 186.59 Million CNY | 42.91% |
| 2020 Q2 | 175.29 Million CNY | 96.54% |
| 2020 Q3 | 163.11 Million CNY | -6.95% |
| 2020 FY | 605.68 Million CNY | 30.12% |
| 2020 Q1 | 89.19 Million CNY | -27.42% |
| 2020 Q4 | 178.08 Million CNY | 9.18% |
| 2019 Q2 | 124.93 Million CNY | 51.07% |
| 2019 FY | 465.49 Million CNY | 25.32% |
| 2019 Q1 | 82.7 Million CNY | -6.15% |
| 2019 Q4 | 122.88 Million CNY | -8.95% |
| 2019 Q3 | 134.96 Million CNY | 8.03% |
| 2018 Q4 | 88.11 Million CNY | -18.45% |
| 2018 Q1 | 68.58 Million CNY | -19.41% |
| 2018 Q3 | 108.05 Million CNY | 1.27% |
| 2018 Q2 | 106.69 Million CNY | 55.56% |
| 2018 FY | 371.45 Million CNY | 25.68% |
| 2017 Q1 | 56.46 Million CNY | 11.51% |
| 2017 FY | 295.55 Million CNY | 34.76% |
| 2017 Q4 | 85.1 Million CNY | 8.04% |
| 2017 Q3 | 78.77 Million CNY | 4.74% |
| 2017 Q2 | 75.21 Million CNY | 33.2% |
| 2016 Q3 | 60.51 Million CNY | 0.0% |
| 2016 FY | 219.32 Million CNY | 16.35% |
| 2016 Q4 | 50.63 Million CNY | -16.33% |
| 2015 FY | 188.5 Million CNY | 35.33% |
| 2014 FY | 139.28 Million CNY | 43.88% |
| 2013 FY | 96.81 Million CNY | 0.0% |